Document Detail


Glutaconyl-CoA is the main toxic agent in glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type I).
MedLine Citation:
PMID:  15922108     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Despite early diagnosis and treatment, 35% of the patients with glutaric aciduria type I (GA I) develop severe neurologic damage. Glutaric acid and 3-hydroxyglutaric acid have been suspected to cause neurodegeneration. Lately, this has been questioned, however. We postulate that glutaconyl Coenzyme A (glutaconyl-CoA) is responsible for brain damage. Chemically, glutaconyl-CoA is an analogue of acrylyl-CoA, the parent substance of the extremely reactive class of acrylates. It is expected to react spontaneously with sulfhydryl groups, thus modifying membranes, disturbing enzyme functions and trapping glutathione. Enhanced production of glutaconyl-CoA together with lack of glutathione precipitates brain damage. Such a mechanism is supported by three findings. (1) The addition product of glutaconyl-CoA to cysteine is present in small amounts in normal human urine. (2) Reaction of methacrylyl-CoA with free sulfhydryl groups has been reported previously in a patient with 3-hydroxyisobutyryl CoA deacylase deficiency. (3) Glutathione has been found to be decreased in homozygous glutaryl-CoA dehydrogenase-deficient knock-out mice.
Authors:
Willy Lehnert; Jörn Oliver Sass
Related Documents :
20488028 - Decreased biosynthesis of saturated c20-c24 fatty acids by the trembler mouse sciatic n...
15138278 - A fatty acid synthase blockade induces tumor cell-cycle arrest by down-regulating skp2.
9374128 - Phytanic acid alpha-oxidation: decarboxylation of 2-hydroxyphytanoyl-coa to pristanic a...
15590268 - Metabolic regulation of leptin production in adipocytes: a role of fatty acid synthesis...
10591018 - Catabolic pathways of glucose in bacillus circulans var. alkalophilus.
591268 - Treatment of oral estramustine phosphate (estracyt) in prostatic carcinoma: influences ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Medical hypotheses     Volume:  65     ISSN:  0306-9877     ISO Abbreviation:  Med. Hypotheses     Publication Date:  2005  
Date Detail:
Created Date:  2005-05-30     Completed Date:  2005-09-16     Revised Date:  2005-11-17    
Medline Journal Info:
Nlm Unique ID:  7505668     Medline TA:  Med Hypotheses     Country:  Scotland    
Other Details:
Languages:  eng     Pagination:  330-3     Citation Subset:  IM    
Affiliation:
Stoffwechsellabor, Zentrum für Kinderheilkunde- und Jugendmedizin, Universitätsklinikum Freiburg, Mathildenstr. 1, D-79106 Freiburg, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acyl Coenzyme A / pharmacology*
Amino Acid Metabolism, Inborn Errors / metabolism
Animals
Brain / metabolism
Cysteine / chemistry
Glutaryl-CoA Dehydrogenase
Glutathione / metabolism
Humans
Mice
Mice, Knockout
Models, Chemical
Models, Theoretical
Oxidoreductases Acting on CH-CH Group Donors / deficiency*
Chemical
Reg. No./Substance:
0/Acyl Coenzyme A; 52-90-4/Cysteine; 6712-05-6/glutaconyl-coenzyme A; 70-18-8/Glutathione; EC 1.3.-/Oxidoreductases Acting on CH-CH Group Donors; EC 1.3.99.7/Glutaryl-CoA Dehydrogenase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Non-termination of sickness behavior as precipitating factor for mental disorders.
Next Document:  Immunoliposome-mediated delivery of neomycin phosphotransferase for the lineage-specific selection o...